Literature DB >> 19303394

Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy.

Yanling Zhang1, Qingxian Zhang.   

Abstract

Specific therapies of diabetic nephropathy (DN) are not available, and current treatment strategies are limited to management of blood glucose levels and control of hypertension. The re-activation of developmental programs in DN suggests new potential therapeutic targets. Bone morphogenetic protein-7 (BMP-7) and its antagonist, Gremlin is revealed to be involved in renal development and diabetic nephropathy. This article reviews the changes of BMP-7 and Gremlin in diabetic kidney, the protective effects on diabetic nephropathy when targeting BMP-7 and Gremlin, and the possible mechanism. The reorganization of the re-activation of Gremlin and BMP-7 in diabetic kidney had shed light on the identification of novel therapeutic targets for DN.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19303394     DOI： 10.1016/j.bbrc.2009.03.086

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Update in new anabolic therapies for osteoporosis.

Authors:  Ernesto Canalis
Journal:  J Clin Endocrinol Metab       Date:  2010-04       Impact factor: 5.958

2.  Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.

Authors:  Kristof Nolan; Chandramohan Kattamuri; David M Luedeke; Elizabeth B Angerman; Scott A Rankin; Mariana L Stevens; Aaron M Zorn; Thomas B Thompson
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 3.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

4.  Overexpression of Gremlin promotes non-small cell lung cancer progression.

Authors:  Yunhong Yin; Yie Yang; Liyun Yang; Yan Yang; Chunyu Li; Xiao Liu; Yiqing Qu
Journal:  Tumour Biol       Date:  2015-09-21

5.  No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells.

Authors:  Louise R Dutton; Christina L O'Neill; Reinhold J Medina; Derek P Brazil
Journal:  J Biol Chem       Date:  2019-10-11       Impact factor: 5.157

6.  Renal outcomes in patients with type 1 diabetes and macroalbuminuria.

Authors:  Ian H de Boer; Maryam Afkarian; Tessa C Rue; Patricia A Cleary; John M Lachin; Mark E Molitch; Michael W Steffes; Wanjie Sun; Bernard Zinman
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

7.  Effects of Panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus.

Authors:  Qing-nian Tu; Hui Dong; Fu-er Lu
Journal:  Chin J Integr Med       Date:  2011-08-09       Impact factor: 1.978

Review 8.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

Review 9.  Growth factor control of bone mass.

Authors:  Ernesto Canalis
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

10.  Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Jarrod W Barnes; Elif T Kucera; Liping Tian; Noël E Mellor; Nina Dvorina; William W Baldwin; Micheala A Aldred; Carol F Farver; Suzy A A Comhair; Metin Aytekin; Raed A Dweik
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.